Table 2 Relationship between TMED3 expression patterns and characteristics of tumor or EC patients
From: Depleting TMED3 alleviates the development of endometrial carcinoma
Characteristics | No. of patients | TMED3 expression pattern | P | |
|---|---|---|---|---|
Low | High | |||
All patients | 33 | 19 | 14 | Â |
Age (years old) | ||||
  ≤ 55# | 17 | 10 | 7 | 0.883 |
  > 55 | 16 | 9 | 7 | |
Tumor size (cm) | ||||
  < 3.5# | 9 | 6 | 3 | 0.357 |
  ≥ 3.5 | 9 | 4 | 5 | |
Grade | ||||
 I | 3 | 2 | 1 | 0.781 |
 II | 19 | 11 | 8 | |
 III | 9 | 5 | 4 | |
Tumor infiltration | ||||
T1 | 18 | 11 | 7 | 0.543 |
 T2 | 5 | 5 | 0 | |
 T3 | 5 | 1 | 4 | |
Lymphatic metastasis (N) | ||||
 N0 | 22 | 15 | 7 | 0.038 |
 N1 | 8 | 2 | 6 | |
Stage | Â | |||
 1 | 17 | 10 | 7 | 0.438 |
 2 | 5 | 5 | 0 | |
 3 | 9 | 3 | 6 | |
 4 | 2 | 1 | 1 | |
Metastasis (M) | ||||
 M0 | 31 | 18 | 13 | 0.826 |
 M1 | 2 | 1 | 1 | |